CDMRP: Autism Research Program - Idea Development Award & Clinical Trial Award

Name: CDMRP: Autism Research Program - Idea Development Award & Clinical Trial Award
Application deadline: 10/06/15
General description:

Idea Development Award: supports innovative/high-risk/high-reward projects leading to critical that will accelerate progress in improving outcomes for individuals with autism in these areas: Assessment of novel therapeutics using valid preclinical models / Environmental risk factors / Mechanisms of heterogeneous clinical expression of ASD Mechanisms / underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, aggression, depression, and anxiety). http://www.grants.gov/web/grants/view-opportunity.html?oppId=275941 

- Clinical Trial Award: seeks applications from all areas in clinical research, and strongly addressing the critical needs of the autism spectrum disorder (ASD) community in the following areas: Behavioral, cognitive, and other non-pharmacological therapies / Pharmacological treatments in autism or well-defined subgroups of autism / Dissemination/Implementation of efficacious behavioral interventions / Therapies to alleviate conditions co-occurring with ASD. http://www.grants.gov/web/grants/view-opportunity.html?oppId=275960 

Topic Areas for these opportunities:

Idea Development Award

  • Assessment of novel therapeutics using valid preclinical models
  • Environmental risk factors
  • Mechanisms of heterogeneous clinical expression of ASD
  • Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, aggression, depression, anxiety)
  • Factors promoting success in key transitions to independence for individuals living with ASD

Clinical Trial Award

  • Behavioral, cognitive, and other non-pharmacological therapies
  • Pharmacological treatments in autism or well-defined subgroups of autism
  • Dissemination/Implementation of efficacious behavioral interventions (including measures of fidelity and outcomes)
  • Therapies to alleviate conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, aggression, depression, anxiety)

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=42901 

Source: Foreign
Budget: IDA $340,000; CTA $1-million
Number of research years: IDA 3 yrs; CTA 4 yrs
Contact person: Robi – 2152, robertg@technion.ac.il, Michael - 1769, MichaelKM@trdf.technion.ac.il
Fields: Life Sciences and medicine
Type of fund: The fund is not a competitive fund
Related fund and profiles: Congressionally Directed Medical Research Programs - CDMRP ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner)